Akèy › Leukemi limfoblastik ak limfom selil T prekursè › Maryland
Etid klinik pou Leukemi limfoblastik ak limfom selil T prekursè nan Maryland
3 etid pou Leukemi limfoblastik ak limfom selil T prekursè ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 5, 2026 · NCT07388563Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 5, 2026 · NCT06904066Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT01087333Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.